Journal of Tianjin Agricultural University ›› 2017, Vol. 24 ›› Issue (1): 48-51.

• Researches and Scientific Notes • Previous Articles     Next Articles

Cloning and Expression of SUMO-β-arrestin2 Fusion Gene and Purification of Recombinant Protein

ZHANG Yao-fang1, XU Yan-ling1, HUANG Zhi-qiang1, DU Li1, CHEN Xi1, FU yu1, LI Ming-gang2,Corresponding Author   

  1. 1. College of Basic Science, Tianjin Agricultural University, Tianjin 300384, China;
    2. College of Life Science, Nankai University, Tianjin 300071, China
  • Received:2016-06-29 Online:2017-03-31 Published:2019-10-15

Abstract: Type 2 diabetes is acommon chronic disease, and it is associated with insulin resistance. Loss or dysfunction of β-arrestin2 results in the development of insulin resistance and progression of type 2 diabetes. However, administration of β-arrestin2 significantly amend glucose intolerance and insulin resistance. In this article, We fused SUMO and β-arrestin2 gene with recombinant PCR methods, and then inserted it into pET22b vector, and constructed a expression vector pET22b-SUMO- β-arrestin2 successfully. A recombinant expression plasmid was expressed in Rosetta Blue(DE3)line of E.coli with IPTG at the temperature of 20 ℃. The SUMO-β-arrestin2 fusion protein was purified with Ni-NTA successfully. Lay the foundation for subsequent pharmacodynamic research of β-arrestin2.

Key words: β-arrestin2, diabetic, expression, purify

CLC Number: